---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-21-000145"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2021-07-01T23:59:59+00:00"
generated_at: "2026-06-30T08:04:19.584562+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BeiGene appoints Julia Wang as CFO; Howard Liang retires effective June 30, 2021

## Summary
- Julia Wang named CFO, principal financial and accounting officer, effective June 30, 2021.
- Annual base salary $445,000; bonus target 50% of base; equity grants vesting over four years.
- Prior CFO Howard Liang retired; no disagreement regarding financial reporting or accounting.
- Liang entered 4-month consulting agreement; unvested options continue to vest during term.
- Wang previously SVP Enterprise Optimization & Deputy CFO; prior roles at Alexion, Quest, J&J.

## SEC filing metadata
- accession: 0001651308-21-000145
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2021-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/0001651308-21-000145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/bgne-20210630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-21-000145
- JSON: https://secwatch.observer/filing/0001651308-21-000145.json
- Plain text: https://secwatch.observer/filing/0001651308-21-000145.txt

## Key facts
- Executive change
  Howard Liang retired as Chief Financial Officer and Chief Strategy Officer at BeOne Medicines Ltd..
  - Action: retired
  - Role: Chief Financial Officer and Chief Strategy Officer
  source text: On June 30, 2021, Howard Liang, Ph.D., Chief Financial Officer and Chief Strategy Officer, retired from the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/0001651308-21-000145-index.htm
- Executive change
  Julia Wang was appointed as Chief Financial Officer at BeOne Medicines Ltd..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: on June 30, 2021, Julia Wang became the Chief Financial Officer of BeiGene, Ltd.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/0001651308-21-000145-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.